Connor, Clark & Lunn Investment Management Ltd. Abbott Laboratories Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 91,865 shares of ABT stock, worth $10.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

91,865

Previous 31,950 187.53%

Holding current value

$10.5 Million

Previous $3.32 Million 215.55%

% of portfolio

0.06%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $6 Million - $7.08 Million	59,915 Added 187.53%	91,865 $10.5 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $42.4 Million - $47.4 Million	-421,336 Reduced 92.95%	31,950 $3.32 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $20.3 Million - $22.4 Million	-185,014 Reduced 28.99%	453,286 $51.5 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $43.6 Million - $53.4 Million	483,493 Added 312.32%	638,300 $70.3 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $14.8 Million - $17.7 Million	154,807 New	154,807 $15 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $16 Million - $18.8 Million	-164,794 Reduced 30.27%	379,574 $38.4 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $37.9 Million - $44.5 Million	398,631 Added 273.53%	544,368 $59.8 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $20.9 Million - $24.2 Million	-216,173 Reduced 59.73%	145,737 $14.1 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $13.9 Million - $16.8 Million	135,872 Added 60.11%	361,910 $39.3 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $25.6 Million - $31.2 Million	224,249 Added 12534.88%	226,038 $26.8 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $27.4 Million - $33.5 Million	-236,804 Reduced 99.25%	1,789 $252,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2.24 Million - $2.48 Million	-19,221 Reduced 7.46%	238,593 $28.2 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $8.69 Million - $10.2 Million	-82,146 Reduced 24.16%	257,814 $29.9 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $9.89 Million - $11.7 Million	-90,882 Reduced 21.09%	339,960 $40.7 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $27.4 Million - $29.9 Million	261,422 Added 154.3%	430,842 $47.2 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $13 Million - $15.8 Million	141,826 Added 513.97%	169,420 $18.4 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $2.79 Million - $3.57 Million	-36,406 Reduced 56.88%	27,594 $2.52 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $599,742 - $876,987	-9,547 Reduced 12.98%	64,000 $5.05 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $5.58 Million - $6.21 Million	71,025 Added 2816.22%	73,547 $6.39 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $206,400 - $223,802	2,522 New	2,522 $211,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Abbott Laboratories Transaction History